K913650

Substantially Equivalent

DRUG TESTING ASSESSMENT PROGRAM QUALITY CONTROL

Applicant
Duo Research, Inc.
Product code
DIF
Advisory panel
Clinical Toxicology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Annapolis, MD, US
Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.